European Pharmaceutical Law Review Impact Factor in Pharmaceutics Journals

About European Pharmaceutical Law Review

European Pharmaceutical Law Review is a journal covering the technologies/fields/categories related to Drug Discovery (Q4); Law (Q4); Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4). It is published by Lexxion Verlagsgesellschaft mbH. The overall rank of European Pharmaceutical Law Review is 24572.According to SCImago Journal Rank (SJR), this journal is ranked 0.116. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 2. The best quartile for this journal is Q4.The ISSN of European Pharmaceutical Law Review journal is 25117157, 25117181.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. European Pharmaceutical Law Review is cited by a total of 8 articles during the last 3 years (Preceding 2022).